Mineralocorticoid Receptor Antagonists: New Extended Roles in Cardio- And Nephroprotection

Medical Council
doi 10.21518/2079-701x-2018-5-58-63
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Remedium, Ltd.

Related search

Third-Generation Mineralocorticoid Receptor Antagonists

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2016English

Mineralocorticoid Receptor Antagonists for Heart Failure

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2011English

Incidence, Predictors and Clinical Management of Hyperkalaemia in New Users of Mineralocorticoid Receptor Antagonists

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Managing Resistant Hypertension: Focus on Mineralocorticoid-Receptor Antagonists

Vascular Health and Risk Management
2017English

Mineralocorticoid Receptor Antagonists (MRAs): More Attention Required (To Prescription)!

Kardiologia Polska
Cardiovascular MedicineCardiology
2018English

Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology

Pharmacological Reviews
Molecular MedicinePharmacology
2015English

Mineralocorticoid Receptor Antagonists for Heart Failure: Systematic Review and Meta-Analysis

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2016English

Mineralocorticoid Receptor Antagonists Attenuate Exaggerated Exercise Pressor Reflex Responses in Hypertensive Rats

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2017English

Structure-Based Drug Design of Mineralocorticoid Receptor Antagonists to Explore Oxosteroid Receptor Selectivity

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy